KLK8 and leukemia: As shown in Figure 6b, leukemia cell growth in bone marrow was significantly reduced in the T‐hNP/SnMP +DNR treatment group, at a rate that was 3.68‐fold and 3.56‐fold lower than with hNP/SnMP +DNR and T‐hNP/Empty +DNR groups, respectively.